Company EXACT Therapeutics AS Oslo Bors
Equities
NO0010852213
Biotechnology & Medical Research
Business Summary
Sales per Business
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Acoustic Cluster Therapy
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -99.02% |
Sales per region
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Norway
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -99.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Svein Kvåle
FOU | Founder | - | 31/12/11 |
Per Walday
CEO | Chief Executive Officer | 64 | 27/03/22 |
John Edminson
DFI | Director of Finance/CFO | - | 30/09/22 |
Amir Snapir
CTO | Chief Tech/Sci/R&D Officer | - | 20/09/22 |
Ragnar Bendiksen
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Corporate Officer/Principal | - | 10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Castell
BRD | Director/Board Member | 76 | 21/06/18 |
Director/Board Member | 57 | - | |
Director/Board Member | 53 | 31/12/14 | |
Anders Wold
CHM | Chairman | - | 02/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,080,552 | 10,360,704 ( 32.30 %) | 0 | 32.30 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |